Form 4: Colgate-Palmolive Director Brian Newman Acquires Additional Shares
SEC Form 4 Filing
Director Brian Newman acquired 201 shares of Colgate-Palmolive stock at $93.18 per share on January 2, 2025, increasing his direct holdings to 2,388 shares.
Summary
- On January 2, 2025, Brian Newman, a director of Colgate-Palmolive, acquired 201 shares of common stock at a price of $93.18 per share.
- This acquisition was part of a deferred compensation plan for non-employee directors.
- Following the transaction, Newman directly owns 2,388 shares of Colgate-Palmolive common stock.
- He also has indirect ownership of 36 shares through a family trust.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it simply reports a transaction. The director's purchase could be seen as slightly positive, but it's a small transaction.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
This is a routine disclosure of insider trading activity, which is common among publicly traded companies. It provides transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, but insider transactions are always of interest to shareholders.
Key Dates
| Date | Description |
|---|---|
| 01/06/2024 | Date of signature for the report. |
| 01/02/2025 | Date of the transaction where common stock was acquired. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.